HuGE Literature Finder
Records 1-16
|
Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.
Journal of clinical pharmacology 2019 Apr . Reséndiz-Abarca Carlos Alberto, Flores-Alfaro Eugenia, Suárez-Sánchez Fernando, Cruz Miguel, Valladares-Salgado Adán, Del Carmen Alarcón-Romero Luz, Vázquez-Moreno Miguel Alexander, Wacher-Rodarte Niels Agustín, Gómez-Zamudio Jaime Héct |
|
Effects of SLC22A2 (rs201919874) and SLC47A2 (rs138244461) genetic variants on Metformin Pharmacokinetics in Pakistani T2DM patients.
JPMA. The Journal of the Pakistan Medical Association 2019 Feb 69 (2): 155-163. Moeez Sadaf, Khalid Zoya, Jalil Fazal, Irfan Muhammad, Ismail Muhammad, Arif Mohammad Ali, Niazi Rauf, Khalid Sumb |
|
Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes.
Pharmacogenomics 2018 Jun . Phani Nagaraja M, Vohra Manik, Kakar Ananth, Adhikari Prabha, Nagri Shivashankara K, D'Souza Sydney C, Umakanth Shashikiran, Satyamoorthy Kapaettu, Rai Padmalatha |
|
Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients.
European journal of endocrinology / European Federation of Endocrine Societies 2016 Sep . Zaharenko Linda, Kalnina Ineta, Geldnere Kristine, Konrade Ilze, Grinberga Solveiga, Židzik Jozef, Javorský Martin, Lejnieks Aivars, Nikitina-Zake Liene, Fridmanis Davids, Peculis Raitis, Radovica-Spalvina Ilze, Hartmane Dace, Pugovics Osvalds, Tká? Ivan, Klim?áková Lucia, Pirags Valdis, Klovins Jan |
|
A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin.
Clinical pharmacology and therapeutics 2016 Jul . Goswami Srijib, Yee Sook Wah, Xu Fei, Sridhar Sneha B, Mosley Jonathan Jd, Takahashi Atsushi, Kubo Michiaki, Maeda Shiro, Davis Robert L, Roden Dan M, Hedderson Monique M, Giacomini Kathleen M, Savic Radojka |
|
The variant organic cation transporter 2 (OCT2)-T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin.
Diabetes research and clinical practice 2015 Apr 108 (1): 78-83. Kashi Zahra, Masoumi Parisa, Mahrooz Abdolkarim, Hashemi-Soteh Mohammad Bagher, Bahar Adele, Alizadeh Ah |
|
Polymorphism of organic cation transporter 2 improves glucose-lowering effect of metformin via influencing its pharmacokinetics in Chinese type 2 diabetic patients.
Molecular diagnosis & therapy 2015 Feb 19 (1): 25-33. Hou Wolin, Zhang Dandan, Lu Wei, Zheng Taishan, Wan Lili, Li Qing, Bao Yuqian, Liu Fang, Jia Weipi |
|
Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.
Clinical pharmacokinetics 2013 May 52 (5): 373-84. Duong Janna K, Kumar Shaun S, Kirkpatrick Carl M, Greenup Louise C, Arora Manit, Lee Toong C, Timmins Peter, Graham Garry G, Furlong Timothy J, Greenfield Jerry R, Williams Kenneth M, Day Richard |
|
Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.
Diabetes, obesity & metabolism 2013 Feb 15 (2): 189-91. Tká? I, Klim?áková L, Javorský M, Fabianová M, Schroner Z, Hermanová H, Babjaková E, Tká?ová |
|
Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
Pharmacogenetics and genomics 2012 Sep 22 (9): 659-66. Tarasova Linda, Kalnina Ineta, Geldnere Kristine, Bumbure Alda, Ritenberga Rota, Nikitina-Zake Liene, Fridmanis Davids, Vaivade Iveta, Pirags Valdis, Klovins Jan |
|
Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program.
Diabetes 2010 Oct 59 (10): 2672-81. Jablonski Kathleen A, McAteer Jarred B, de Bakker Paul I W, Franks Paul W, Pollin Toni I, Hanson Robert L, Saxena Richa, Fowler Sarah, Shuldiner Alan R, Knowler William C, Altshuler David, Florez Jose C, |
|
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Diabetes care 2010 Oct 33 (10): 2250-3. Bailey Swneke D, Xie Changchun, Do Ron, Montpetit Alexandre, Diaz Rafael, Mohan Viswanathan, Keavney Bernard, Yusuf Salim, Gerstein Hertzel C, Engert James C, Anand Sonia, |
|
Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension.
Annals of medicine 2010 May 42 (4): 296-304. Sallinen Riitta, Kaunisto Mari A, Forsblom Carol, Thomas Merlin, Fagerudd Johan, Pettersson-Fernholm Kim, Groop Per-Henrik, Wessman Maija, |
|
SLC22A2 gene 808 G/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin.
Acta pharmacologica Sinica 2010 Feb 31 (2): 184-90. Li Qing, Liu Fang, Zheng Tai-shan, Tang Jun-ling, Lu Hui-juan, Jia Wei-pi |
|
Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.
Journal of human genetics 2007 52 (2): 117-22. Shikata Eriko, Yamamoto Rei, Takane Hiroshi, Shigemasa Chiaki, Ikeda Tadasu, Otsubo Kenji, Ieiri Ichi |
|
Lower prevalence of the OCT2 Ser270 allele in patients with essential hypertension.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2006 Oct 28 (7): 645-53. Lazar Andreas, Zimmermann Tim, Koch Werner, Gründemann Dirk, Schömig Albert, Kastrati Adnan, Schömig Edg |
- Page last reviewed:Mar 16, 2019
- Page last updated:Apr 09, 2020
- Content source: